Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $890.63 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $187.22 | 7 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $147.65 | 1 | $0 (2024) |
| ABBVIE INC. | $144.76 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $76.54 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $72.34 | 4 | $0 (2024) |
| Celgene Corporation | $60.31 | 4 | $0 (2019) |
| GENZYME CORPORATION | $40.29 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $39.37 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $24.50 | 1 | $0 (2022) |
| Amgen Inc. | $22.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.53 | 14 | Regeneron Healthcare Solutions, Inc. ($165.22) |
| 2023 | $40.93 | 2 | Novartis Pharmaceuticals Corporation ($21.64) |
| 2022 | $137.65 | 7 | Janssen Biotech, Inc. ($44.48) |
| 2021 | $38.13 | 2 | Regeneron Healthcare Solutions, Inc. ($22.00) |
| 2020 | $15.18 | 1 | AbbVie Inc. ($15.18) |
| 2019 | $61.63 | 4 | Novartis Pharmaceuticals Corporation ($24.47) |
| 2017 | $121.58 | 8 | Celgene Corporation ($41.67) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/02/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $147.65 | General |
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Inflammation | ||||||
| 10/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Dermatology | ||||||
| 05/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/14/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Immunology | ||||||
| 12/09/2022 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Dermatology | ||||||
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Immunology | ||||||
| 08/07/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Immunology | ||||||
| 08/02/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 05/04/2022 | ABBVIE INC. | RINVOQ (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/08/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,222 | 2,146 | $476,899 | $75,470 |
| 2022 | 13 | 1,315 | 2,346 | $440,312 | $82,849 |
| 2021 | 12 | 1,176 | 2,120 | $399,819 | $83,518 |
| 2020 | 12 | 1,030 | 1,776 | $324,492 | $58,173 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 378 | 519 | $136,497 | $28,041 | 20.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 160 | 184 | $69,552 | $11,826 | 17.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 210 | 268 | $81,373 | $9,783 | 12.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 71 | $29,749 | $5,112 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $26,964 | $4,815 | 17.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 144 | 780 | $65,520 | $3,716 | 5.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 47 | 91 | $18,655 | $3,388 | 18.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 26 | $19,092 | $3,067 | 16.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 59 | 67 | $9,885 | $2,526 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 19 | $7,068 | $1,478 | 20.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 17 | $8,075 | $984.21 | 12.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $4,469 | $734.32 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 380 | 524 | $98,784 | $28,048 | 28.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 158 | 177 | $50,769 | $11,858 | 23.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 223 | 284 | $86,231 | $10,593 | 12.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 99 | 99 | $28,812 | $6,385 | 22.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 70 | 75 | $25,619 | $4,934 | 19.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 29 | 40 | $29,372 | $4,683 | 15.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 157 | 887 | $65,532 | $4,278 | 6.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 57 | 100 | $15,471 | $3,898 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 83 | $12,245 | $2,878 | 23.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 25 | 26 | $9,381 | $2,307 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 16 | $4,371 | $1,379 | 31.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 22 | 22 | $4,916 | $982.32 | 20.0% |
| 69100 | Biopsy of ear | Office | 2022 | 13 | 13 | $8,809 | $627.56 | 7.1% |
About Dr. Michelle Lewis, MD
Dr. Michelle Lewis, MD is a Dermatology healthcare provider based in Appleton, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801802046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Lewis, MD has received a total of $890.63 in payments from pharmaceutical and medical device companies, with $475.53 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($890.63).
As a Medicare-enrolled provider, Lewis has provided services to 4,743 Medicare beneficiaries, totaling 8,388 services with total Medicare billing of $300,010. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Appleton, WI
- Active Since 07/31/2006
- Last Updated 08/12/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801802046
Products in Payments
- DUPIXENT (Biological) $187.22
- TREMFYA (Drug) $76.54
- SKYRIZI (Biological) $69.86
- COSENTYX (Drug) $47.87
- BOTOX (Biological) $42.29
- DERMATITIS - DISEASE (Drug) $40.29
- Sotyktu (Drug) $39.37
- RINVOQ (Biological) $32.61
- BLU-U (Medical Supply) $24.50
- COSENTYX (Biological) $24.47
- Otezla (Drug) $22.33
- DUPIXENT (Drug) $18.52
- ELIDEL (Drug) $17.37
- TALTZ (Drug) $17.18
- ORACEA (Drug) $11.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Appleton
Dr. Peter Katz, Md, MD
Dermatology — Payments: $2,600
Dr. Keith Wagner, M.d, M.D
Dermatology — Payments: $703.65
Noah Smith, Md, MD
Dermatology — Payments: $78.30
Brent Weed, M.d, M.D
Dermatology
Dr. Charles Kagen, M.d, M.D
Dermatology